Medical Specialty >> Pharmacy
More Opioid Users Getting Treatment Since Medicaid Expansion
2:00 PM CDT.
By Steven ReinbergHealthDay Reporter Read article
- FDA Approves Brain Stimulation Device for OCD
- Generic EpiPen Gains Doctors’ Approval
- FDA Approves 1st Generic EpiPen
- New Drug of Last Resort Tackles Resistant HIV
JOURNAL UPDATE
Comments Open on End of NIH Review for Gene Therapy Studies
7:00 PM CDT. NIH oversight panel no longer plans to review all applications for gene therapy experiments- Honey May Protect Children Who Swallow Button Batteries
- QI Program Can Up Outcomes for Neonatal Abstinence Syndrome
- CDC: Increase in Tianeptine Exposures From 2014 to 2017
MONTHLY JOURNAL SUMMARY
July 2018 Briefing - Pharmacy
August 01, 2018. The Monthly Journal Summary is a single article covering the most important journal articles published in the previous 30 days.
FEATURED ARTICLES
Rucaparib Maintenance Therapy Improves PFS in Platinum-sensitive Ovarian Cancer - The ARIEL3 Trial
Robert L. Coleman, MD.
Professor Robert L. Coleman M.D., FACOG, FACS discusses the implications of data from the Phase 3 ARIEL3 trial of the novel PARP inhibitor rucaparib as maintenance therapy in patients with platinum-sensitive ovarian cancer. Professor Coleman is the Vice Chair of Clinical Research in the Department of…
Investigational Topical Minocycline Gel for Acne Advances to Phase III Development
Ted Lain, MD.
Clinical trial investigator Dr. Ted Lain comments on the results of the OPAL study, a Phase 2b clinical trial which evaluated the efficacy of a novel topical gel formulation of the antibiotic minocycline (BPX-01) in reducing the number of inflammatory lesions in patients with moderate-to-severe inflammatory,…
Bevacizumab for breast cancer: FDA grants a stay of execution
Dr. Alberto De la Guerra.
The Food and Drug Administration has after repeated delays proposed removing metastatic breast cancer as an indication from the Avastin label. The proposal is being contested by Roche/Genentech, the drug’s maker. In this article we review the evidence for and against this decision.
MEDICAL FOCUS
DISCUSSION
RE: Investigational Topical Minocycline Gel for Acne Advances to Phase III Development
By MrRobinGreat articles. learnt a lot from it.
